Selective COX-2 inhibition improves endothelial function in coronary artery disease.
Chenevard R, Hürlimann D, Béchir M, Enseleit F, Spieker L, Hermann M, Riesen W, Gay S, Gay RE, Neidhart M, Michel B, Lüscher TF, Noll G, Ruschitzka F.
Chenevard R, et al. Among authors: enseleit f.
Circulation. 2003 Jan 28;107(3):405-9. doi: 10.1161/01.cir.0000051361.69808.3a.
Circulation. 2003.
PMID: 12551863
Clinical Trial.